4N6FLOQSwabs® Genetics is the line of Copan patented FLOQSwabs® specifically designed and dedicated to DNA collection for human identification.
hDNAfreeFLOQSwabs® is a product line dedicated to DNA collection for genetic applications. Free of amplifiable human DNA and detectable DNase and RNase, hDNAFLOQSwabs® are non-invasive, painless, and cost-effective.
Self – Lollisponge™
LolliSponge™ easiness allows saliva collection from non-collaborative patients or when professional assistance is not available, enabling COVID-19 active surveillance programs in fragile communities.
A successful forensic investigation begins with a proper sample, and proper samples are obtained using the appropriate collection method.
A prospective study evaluating congenital CMV infection in Mayotte and La Reunion Islands (France)
Justine Demortier, Jacques Fourgeaud, Soumeth Abassed, LaurentLambrecht, Marie Gromand, Brahim Boumahni, Coralie Dumont, Alexandre Reynaud, Margaux Avet, Louis Collet, Claire Périllaud-Dubois, Marie-Christine Jaffar-Bandjee, Christelle Vauloup-Fellous
Saliva collected in universal transport media is an effective, simple and high-volume amenable method to detect SARS-CoV-2
Byron M. Berenger, John M. Conly, Kevin Fonseca, Jia Hu, Thomas Louie, Angela R. Schneider, Takshveer Singh, William Stokes, Linda Ward, Nathan Zelyas
Characterization of a universal screening approach for congenital CMV infection based on a highly-sensitive, quantitative, multiplex real-time PCR assay
Inactivation of SARS-CoV-2 virus in saliva using a guanidium based transport medium suitable for RT-PCR diagnostic assays
Bacterial Load of Chlamydia trachomatis in the Posterior Oropharynx, Tonsillar Fossae, and Saliva among Men Who Have Sex with Men with Untreated Oropharyngeal Chlamydia
Tiffany R. Phillips
Copan microFLOQ® Direct Swab collection of bloodstains, saliva, and semen on cotton cloth
Allison J Sherier
Saliva detection of SARS-CoV-2 for mitigating company outbreaks: a surveillance experience
Emerenziana Ottaviano et al.
Sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testing
Banada et al.
Launch of LolliSponge™
We are proud to present LolliSponge™, the new sponge-made saliva collection device we conceived by listening to the healthcare professionals’ needs!
LolliSponge™ easiness allows saliva collection from non-collaborative patients or when professional assistance is not available, enabling COVID-19 active surveillance programs in fragile communities and making personnel available for other activities such as vaccine administration.
Microbiology Time – August 2021
It’s August Microbiology Time! We just updated our website’s scientific database and chose the best three papers of the month: a study on extrapulmonary samples processing with MycoTB™, an alternative to PCR for Sars-CoV-2 diagnosis, and the first feedback from the LolliSponge™ use to collect saliva for COVID-9 screening.
Microbiology Time – October 2021
October’s update of our scientific database is full of exciting papers. Among them, we selected a study on HPV-related cancer screening, a research on direct amplification of disaster victim identification samples, and a comparison of sample collection and transport methods to enhance yield and biosafety of COVID-19 testing.
Lollisponge™ – The sponge-made device for saliva collection
LolliSponge™ is our device conceived to enable active surveillance programs even when professional assistance is not available. Saliva collection with LolliSponge™ is performed just by keeping the sponge stick in the mouth for a few minutes, without any spitting-related risk; this easy procedure can be performed at POC as well as at home, using Lollisponge™ as a self-collection device. A dry device free of hazardous media, Lollisponge™ can be transported to the lab without any liquid-related problem, where it can be centrifuged and tested with the standard molecular diagnostic assays.